Key player · Company profile
Novartis AG
Named as a key player in 627 of our reports, across 33 regions and countries.
Named as a key player in 627 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
Australia 19
Brazil 19
Canada 19
China 19
Ecuador 19
Egypt 19
France 19
Germany 19
Hong Kong 19
India 19
Italy 19
Japan 19
Kenya 19
Malaysia 19
Mexico 19
New Zealand 19
Philippines 19
Russia 19
Saudi Arabia 19
Singapore 19
South Africa 19
Spain 19
Thailand 19
UAE 19
UK 19
US 19| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Over The Counter (OTC) Drugs | OTC & Nutraceuticals | $178 Bn | 4.7% |
| Over The Counter (OTC) Pharmaceuticals | OTC & Nutraceuticals | $178 Bn | 4.7% |
| Oncology/Cancer Drugs | Pharmaceuticals | $177 Bn | 8.4% |
| Asthma & COPD Drugs | Pharmaceuticals | $49.5 Bn | 4% |
| Biosimilars | Pharmaceuticals | $36.9 Bn | 24.9% |
| Over The Counter (OTC) Analgesics | OTC & Nutraceuticals | $22 Bn | 3.4% |
| Anti-Depressants Drugs | Pharmaceuticals | $18 Bn | 2.7% |
| Cell Based Immunotherapy | Pharmaceuticals | $16.6 Bn | 23% |
| Diabetic Retinopathy Drugs | Pharmaceuticals | $10.8 Bn | 6% |
| Epilepsy Drugs | Pharmaceuticals | $9.6 Bn | 3.5% |
| Over The Counter (OTC) Sleep Aid Products | OTC & Nutraceuticals | $5.3 Bn | 4% |
| Over The Counter (OTC) Ophthalmic Drugs | OTC & Nutraceuticals | $3.6 Bn | 4.5% |
| Alexipharmic Drugs | Pharmaceuticals | – | – |
| Alopecia areata | Healthcare Services | – | – |
| Alzheimer Drugs | Pharmaceuticals | – | – |
| Anthelmintic Drug | OTC & Nutraceuticals | – | – |
| Atherosclerosis Drugs | Pharmaceuticals | – | – |
| Axial Spondyloarthritis (axSpA) | Pharmaceuticals | – | – |
| Biosimilar Monoclonal Antibodies | Pharmaceuticals | – | – |
Named as key players in the same markets as Novartis AG (number of shared markets).
Pfizer Inc.12 shared markets
AstraZeneca8 shared markets
Merck & Co., Inc.8 shared markets
Johnson & Johnson7 shared markets
AbbVie Inc.5 shared markets
Bayer AG5 shared markets
GSK PLC5 shared markets
Sanofi5 shared markets